Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations

Hepatology

Volumn 59, Issue 2, 2014, Pages 661-670

  Kleiner, David E ^a   Chalasani, Naga P ^b   Lee, William M ^c   Fontana, Robert J ^d   Bonkovsky, Herbert L ^e   Watkins, Paul B ^f   Hayashi, Paul H ^f   Davern, Timothy J ^g   Navarro, Victor ^h   Reddy, Rajender ⁱ   Talwalkar, Jayant A ^j   Stolz, Andrew ^k   Gu, Jiezhun ^l   Barnhart, Huiman ^l   Hoofnagle, Jay H ^m  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e CAROLINAS MEDICAL CENTER   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j Mayo Clinic   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^m NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANABOLIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; MINOCYCLINE; NITROFURANTOIN;

ACUTE LIVER FAILURE; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BLEEDING; CHILD; CHOLESTASIS; CHOLESTATIC HEPATITIS; CHRONIC HEPATITIS; DISEASE ASSOCIATION; EOSINOPHIL; FEMALE; GRANULOMA; HEPATITIS; HUMAN; HUMAN TISSUE; INJURY SEVERITY; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROSETTE FORMATION; SCHOOL CHILD; STEATOSIS; TOXIC HEPATITIS; VERY ELDERLY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOPSY; CHILD; CHOLESTASIS; CHRONIC DISEASE; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATITIS; HUMANS; LIVER; MALE; MIDDLE AGED; NECROSIS; PHENOTYPE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84893699696     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26709     Document Type: Article

References (22)

1. Fontana RJ, Seeff LB, Andrade RJ, Bjornsson E, Day CP, Serrano J, Hoofnagle JH. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010;52:730-742.
2. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-954.
3. Lee WM, Senior JR. Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol 2005;33:155-164.
4. Shapiro MA, Lewis JH. Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. Clin Liver Dis 2007;11:477-505.
5. Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008;135:1924-1934, 1934.e1-4.
6. Kleiner DE. The pathology of drug-induced liver injury. Semin Liver Dis 2009;29:364-372.
7. Ramachandran R, Kakar S. Histological patterns in drug-induced liver disease. J Clin Pathol 2009;62:481-492.
8. Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, et al. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf 2009;32:55-68.
9. Rockey DC, Seeff LB, Rochon J, Freston J, Chalasani N, Bonacini M, et al.; US Drug-Induced Liver Injury Network. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology 2010;51:2117-2126.
10. Kleiner DE, Chalasani NP, Conjeevaram HS, Bonkovsky HL, Russo MW, Davern TJ, et al. Relationship of biochemical to histologic findings and the pathological pattern of injury among cases identified in the NIH Drug-Induced Liver Injury Network (DILIN) Study. Gastroenterology 2007;132:A773.
11. Zimmerman HJ. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 1999.
12. Zimmerman HJ, Ishak KG: Hepatic injury due to drugs and toxins. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Pathology of the Liver. London: Churchill Livingstone; 2002:621-710.
13. MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP. Pathology of the Liver. London: Churchill Livingstone; 2002.
14. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-1330.
15. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
16. Katoonizadeh A, Nevens F, Verslype C, Pirenne J, Roskams T. Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int 2006;26:1225-1233.
17. Bjornsson E, Kalaitzakis E, Olsson R. The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury. Aliment Pharmacol Ther 2007;25:1411-1421.
18. Babany G, Mallat A, Zafrani ES, Saint-Marc Girardin MF, Carcone B, Dhumeaux D. Chronic liver disease after low daily doses of amiodarone. Report of three cases. J Hepatol 1986;3:228-232.
19. Holmberg L, Boman G, Bottiger LE, Eriksson B, Spross R, Wessling A. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 1980;69:733-738.
20. Iwarson S, Lindberg J, Lundin P. Nitrofurantoin-induced chronic liver disease. Clinical course and outcome of five cases. Scand J Gastroenterol 1979;14:497-502.
21. Pessayre D, Mansouri A, Berson A, Fromenty B. Mitochondrial involvement in drug-induced liver injury. Handb Exp Pharmacol 2010:311-365.
22. Suzuki A, Brunt EM, Kleiner DE, Miquel R, Smyrk TC, Andrade RJ, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011;54:931-939.